Novo Nordisk unsure about chance of reaching upper growth target: "This would require significant changes"
With two months until New Year, Novo Nordisk still does not know whether this year will generate a 5 or 8 percent sales growth. Most likely, it will land somewhere in the middle.
BY KEVIN GRØNNEMANN, TRANSLATED BY NIELSINE NIELSEN
2020 only has two months left, but the Covid-19 pandemic is generating so much uncertainty Novo Nordisk cannot predict whether it will land on a 5, 6, 7 or 8 percent growth in revenue this year.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Cluster CEO hopes for Danish Novo membership
For subscribers
